Plasma concentrations of soluble cytokine receptors in euthymic bipolar patients with and without subsyndromal symptoms

• Main Authors: Cetin Turan, Guloksuz Sinan, Cetin Esin, Gazioglu Sema, Deniz Gunnur, Oral E, van Os Jim
• Format: Article
• Language: English
• Published: BMC 2012-09-01
• Series: BMC Psychiatry
• Subjects: Bipolar disorder; Cytokine; Interleukin; Inflammation; Tumor necrosis factor; Euthymic; Subsyndromal; Staging; Biomarker
• Online Access: http://www.biomedcentral.com/1471-244X/12/158

<p>Abstract</p> <p>Background</p> <p>Current evidence suggests that high concentrations of pro-inflammatory markers are associated with bipolar disorder characterized by severe impairment during inter-episodic periods, reduced treatment response and persistent subsyndromal symptoms. We tested whether persistent subsyndromal symptoms in euthymic bipolar patients were associated with markers of an ongoing chronic pro-inflammatory process.</p> <p>Methods</p> <p>Forty-five euthymic bipolar patients (22 with subsyndromal symptoms (BD+) and 23 without subsyndromal symptoms (BD-) and 23 well controls (WC) were recruited for assessment of soluble tumor necrosis factor receptor-1 (sTNF-R1), soluble interleukin-6 receptor (sIL-6R) and soluble interleukin-2 receptor (sIL-2R) concentrations. Soluble cytokine receptor concentrations were assessed using enzyme-linked immunosorbent assay.</p> <p>Results</p> <p>In comparison to WC, sTNF-R1 concentration was higher in both BD- and BD+ (age and sex adjusted standardized β, respectively: β = 0.34, p = 0.012 and β = 0.41, p = 0.003). Similarly, compared to WC, sIL-6R concentration was higher in both BD- and BD+ (age and sex adjusted standardized β, respectively: β = 0.44, p = 0.001 and β = 0.37, p = 0.008). There was no difference between BD- and BD+ in the concentration of either sTNF-R1 or sIL-6R; plasma concentration of sIL-2R was not analyzed as 75% percent of the samples were non-detectable.</p> <p>Conclusions</p> <p>Although bipolar patients present with a pro-inflammatory shift compared to well controls, subsyndromal symptoms are not associated with additive increasing effects. Longitudinal studies with larger samples are required to clarify the relationship between illness course and inflammatory markers in bipolar disorder.</p>